About
Abrax Japan, Inc is a biopharmaceutical company focused on modulating the immune system by promoting skin production of the cytokine TSLP, initially developing repurposed topical treatments for atopic dermatitis and advancing novel molecular entities for autoimmune diseases.
Explore Abrax Japan, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.